SCHEMBL28406146

SCHEMBL28406146

CCS(=O)(=O)Oc1ccnc(C(F)(F)F)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LOXL2 Q9Y4K0 2/20 0.42
▸ LOX P28300 1/20 0.41
▸ KCNQ2 O43526 1/20 0.38
▸ DDR1 Q08345 1/20 0.37
▸ ADAMTS4 O75173 1/20 0.37
▸ MMP13 P45452 1/20 0.37
▸ CA2 P00918 1/20 0.37
▸ AR P10275 1/20 0.37
▸ TGFBR1 P36897 1/20 0.35
▸ MMP2 P08253 1/20 0.35
▸ MMP7 P09237 1/20 0.35
▸ MMP9 P14780 1/20 0.35
▸ MMP14 P50281 1/20 0.35
▸ MGLL Q99685 1/20 0.35
▸ SMARCA2 P51531 1/20 0.35
▸ SMARCA4 P51532 1/20 0.35
▸ ALPL P05186 1/20 0.35
▸ ALPI P09923 1/20 0.35
▸ PTGS1 P23219 2/20 0.34
▸ PTGS2 P35354 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15720571 0.82 LOXL2 (0.42) LOXL2LOXKCNQ2ADAMTS4MMP13
SCHEMBL29211870 0.79 LOXL2 (0.40) LOXL2LOXKCNQ2ADAMTS4MMP13
SCHEMBL25373119 0.79 CA2 (0.39) LOXL2KCNQ2CA2MMP2MMP7
SCHEMBL1662471 0.78 LOXL2 (0.49) LOXL2LOXARALPLALPI
SCHEMBL27737035 0.77 UHRF1 (0.41) KCNQ2CA2MMP2MMP7MMP9
SCHEMBL28825630 0.76 MMP2 (0.42) CA2MMP2MMP7MMP9MMP14
SCHEMBL28815392 0.76 ALPI (0.43) LOXL2LOXCA2MMP2MMP7
SCHEMBL10200740 0.76 LOXL2 (0.46) LOXL2LOXKCNQ2ARTGFBR1
SCHEMBL27871145 0.76 CA2 (0.39) LOXL2LOXCA2ARMMP2
SCHEMBL1662456 0.74 CCR1 (0.55) LOXL2LOXPTGS1PTGS2NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116981665-A Novel compounds 思瑞万斯公司 2023-10-31 — — CN disclosed
CN-111032656-B Heterocyclic compound kinase inhibitor and pharmaceutical composition and application thereof 捷思英达医药技术(上海)有限公司 2022-12-02 — — CN disclosed
CN-112638917-A Heterocyclic compounds as kinase inhibitors, compositions comprising the heterocyclic compounds, and methods of use thereof 捷思英达控股有限公司 2021-04-09 — — CN disclosed
CN-111032656-A Heterocyclic compound kinase inhibitor and pharmaceutical composition and application thereof 捷思英达医药技术(上海)有限公司 2020-04-17 — — CN disclosed
Send feedback